Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin
about
Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in MiceHydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stressFetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in miceHydrogel Based 3-Dimensional (3D) System for Toxicity and High-Throughput (HTP) Analysis for Cultured Murine Ovarian FolliclesCisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in MiceAMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapyDocetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing folliclesCulture and co-culture of mouse ovaries and ovarian folliclesFolliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspectsEtoposide damages female germ cells in the developing ovary.Challenges and Potential for Ovarian Preservation with SERMs.Irinotecan metabolite SN38 results in germ cell loss in the testis but not in the ovary of prepubertal mice.The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue.The impact of oxaliplatin on the gonads: from bedside to the bench.Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?Ovarian and Uterine Functions in Female Survivors of Childhood Cancers.Control mechanisms in germ cells mediated by p53 family proteins.Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation.In situ cultured preantral follicles is a useful model to evaluate the effect of anticancer drugs on caprine folliculogenesis.Effects of dehydroepiandrosterone supplementation on mice with diminished ovarian reserve.Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovaryAlleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
P2860
Q27345163-029D9DC0-E625-415D-B586-F738D753159CQ28395154-9CBB18F5-F1A3-4A93-BABA-479E46CAEDACQ28541720-9FE3C597-3F35-4303-A14F-50C9A8B0C639Q28550164-5498E0F6-C5C1-436F-A9C5-52687A068656Q28551950-D4523735-DD0B-44FE-A5C9-5662E211E7B0Q30353654-8E760B14-EC8D-4582-AC1C-E2D4956AA268Q34230276-2D982A62-B6F8-4B22-A235-581E9AAEF3A9Q35460812-2160033D-6403-41B4-B3B5-05C12213FE38Q35760872-0A111ACB-C9D1-488A-8822-ECF4716FDF52Q36087872-3D831E58-7DF4-4B13-B52B-777F9F7F2FDFQ36100739-A368F2F4-2B64-4C96-A22C-F27BE7FAC7AFQ36282795-3996738C-E3B2-4C79-A0B4-3BEABD57FEE6Q37400331-1C242329-9B28-42C4-9213-658096354C49Q38296008-58B68D73-A2E7-4324-82A8-E30F2BB1B61FQ38867868-53EA81FB-1F6E-45D1-9376-1F5C0B36209DQ38955776-A4CAC80B-5242-4773-938F-2E6E118826D4Q39026680-8BAE63F1-6882-4A9A-803F-7745438994E5Q47574871-64BE2D3E-1D0A-4910-A239-55D50967E301Q47671672-6D205EF5-2426-4570-BBD1-4ADB44F8F1E2Q47819994-995E9E57-D315-4E32-B3CE-369FB9BEEF13Q48196808-3DDAFBFC-75EC-481C-9FD8-B7D79F20E90DQ49995813-D44DA7EE-6A68-4A7E-BAE1-0D43C2157C22Q55065352-ED2DBAFA-C5E2-4088-8F28-EF15885C4C20Q58712202-CA61BC2C-EA6E-4745-84BF-7C13FA066FE4Q58768664-6FE2CAD2-678C-4476-B63A-5F050DEEB8EC
P2860
Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@ast
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@en
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@nl
type
label
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@ast
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@en
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@nl
prefLabel
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@ast
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@en
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@nl
P2093
P2860
P1433
P1476
Cisplatin and doxorubicin indu ...... tection only against cisplatin
@en
P2093
Charlie Gourley
Federica Lopes
Norah Spears
Richard A Anderson
Stephanie Morgan
P2860
P304
P356
10.1371/JOURNAL.PONE.0070117
P407
P577
2013-07-29T00:00:00Z